These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37009264)

  • 1. Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel.
    Hu J; He Q; Tian T; Chang N; Qian L
    Onco Targets Ther; 2023; 16():197-210. PubMed ID: 37009264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer.
    Zhou F; Wang M; Aibaidula M; Zhang Z; Aihemaiti A; Aili R; Chen H; Dong S; Wei W; Maimaitiaili A
    Med Sci Monit; 2020 Aug; 26():e925147. PubMed ID: 32748897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway.
    Zhan W; Li Y; Liu X; Zheng C; Fu Y
    Cancer Manag Res; 2020; 12():599-610. PubMed ID: 32158264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
    Tan X; Song X; Fan B; Li M; Zhang A; Pei L
    Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPX2 promotes migration and invasion of human breast cancer cells.
    Yang Y; Li DP; Shen N; Yu XC; Li JB; Song Q; Zhang JH
    Asian Pac J Trop Med; 2015 Dec; 8(12):1064-1070. PubMed ID: 26706681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic Non-Small-Cell Lung Cancer Cell-Secreted Exosomal microRNA-582-3p Drives Cancer Cell Malignant Phenotypes by Targeting Secreted Frizzled-Related Protein 1.
    Wang J; Zhao J; Zhu J; Zhang S
    Cancer Manag Res; 2020; 12():10151-10161. PubMed ID: 33116870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the TPX2/NCOA5 axis in regulating proliferation, migration, invasion and angiogenesis of breast cancer cells.
    Wang T; Zhang F; Zhang P
    Exp Ther Med; 2023 Jun; 25(6):304. PubMed ID: 37229326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways.
    Tong L; Wu W
    Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway.
    Hu Y; Mu H; Yang Y
    Histol Histopathol; 2021 Aug; 36(8):869-877. PubMed ID: 34100557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
    Qu L; Tian Y; Wang F; Li Z
    BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
    J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6.
    Li M; Wang Q; Zhang X; Yan N; Li X
    Cancer Cell Int; 2020 Dec; 20(1):574. PubMed ID: 33317527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.